FIBRINOLYTIC EFFECTS OF DIGUANIDES PLUS ETHYLŒSTRENOL IN OCCLUSIVE VASCULAR DISEASE
Authors:
- G.R. FearnleyGFG.R. Fearnley
- R. ChakrabartiRCR. Chakrabarti
- ElizabethD. HockingEHElizabethD. Hocking
- J.F. EvansJEJ.F. Evans
- 1 November 1967
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 290 (7524) , 1008-1011
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- REDUCTION OF PLATELET STICKINESS BY PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1967
- Effect of biguanides and atromid on fibrinolysisJournal of Atherosclerosis Research, 1967
- FIBRINOLYTIC TREATMENT OF RHEUMATOID ARTHRITIS WITH PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1966
- FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASEThe Lancet, 1965
- Measurement of spontaneous fibrinolytic activityJournal of Clinical Pathology, 1964
- Pharmacological enhancement of fibrinolytic activity of bloodJournal of Clinical Pathology, 1964
- Effect of Corticosteroid Therapy on Fibrinolysis in Patients With Inflamatory and Non-inflammatory ConditionsBMJ, 1964
- INCREASE OF BLOOD FIBRINOLYTIC ACTIVITY BY TESTOSTERONEThe Lancet, 1962
- The Intravenous Glucose Tolerance Test in Atherosclerotic Disease with Special Reference to Obesity, Hypertension, Diabetic Heredity and Cholesterol ValuesActa Medica Scandinavica, 1962
- EFFECT OF THE SULPHONYLUREAS ON FIBRINOLYSISThe Lancet, 1960